The Civil Society Forum on Drugs (CSFD), the expert committee of the European Commission in the field of drugs, has identified the enhancement of a gender perspective in EU drug policy as one of the emerging issues of drug policies. In contrast with the previous EU Drug Strategy and Action Plan, the current one seems to incorporate a gender-sensitive approach to all aspects of EU drug policies, which is a significant advancement. However, the recommendations contained in this analysis can help enhance the gender perspectives in the EU drug policy documents. Read the full analysis here.
Image: Freepik.com
Today, in partnership with UNITE, NEWNet and IDPC, we launched the 2024 Manifesto for a Progressive EU Drug Policy, advocating for health, harm reduction, human rights, and evidence-based strategies in drug policy reform in anticipation of the upcoming European Parliament elections. The European Union’s drug policy stands at a critical juncture as we approach the […]
Multiple authors 
Multiple authors
C-EHRN is proud and grateful to present its 2023 Network Report, providing a summarised version of the activities undertaken last year. In this document, we are looking back at a year full of tasks, challenges and opportunities.
Multiple authors
Multiple authors
The European Harm Reduction Conference 2024 invites researchers, practitioners, policymakers, activists, and advocates to submit abstracts for presentations, workshops, and discussions across various tracks to advance harm reduction efforts in Europe and beyond. The conference will be held in Warsaw and will provide a platform for sharing knowledge, experiences, and innovative approaches to harm reduction. Under the […]
Multiple authors
